KKR, a leading global investment firm, today announced that it has received approval from the U.K. government under the National Security and Investment Act 2021 for its proposed £4.2 billion ($5.6 billion) acquisition of Spectris PLC, a high-tech instrument-maker serving the pharmaceutical and semiconductor industries.
This clearance marks an important milestone in the KKR UK Government Approval £4.2B Spectris Takeover, paving the way for the transaction to move toward completion. In addition to the U.K., foreign direct investment authorities in Ireland and Sweden have confirmed that the deal does not require further screening.
The transaction remains subject to regulatory approvals in the European Union, China, and the United States, along with foreign direct investment clearance in Australia and other European jurisdictions. Both companies confirmed that filing processes in these regions are progressing in line with expectations, with completion anticipated by March 2026.
The acquisition is being carried out as a scheme of arrangement under the Companies Act 2006. On August 27, Spectris shareholders approved the transaction at both a general and a court meeting.
Under the agreed terms, KKR will acquire Spectris at £41.75 per share, including a 28 pence dividend. The offer was accepted following a competitive bidding process with Advent International LP.
Spectris has appointed Slaughter and May as its legal adviser. KKR and its bidding entity, Project Aurora Bidco Ltd., are being advised by Kirkland & Ellis International LLP and Simpson Thacher & Bartlett LLP.
This strategic acquisition reflects KKR’s continued commitment to investing in high-growth technology-driven industries and strengthening its global portfolio.
